Renee E. Amori

Journal of the American Medical Association (JAMA) · 2007

A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Whom Renee E. Amori trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Julian P. T. Higgins
  2. S. Thompson
  3. M. Nauck
  4. John B. Buse
  5. Ralph DeFronzo
  6. D. J. Drucker

Who trusts Renee E. Amori overall

  1. D. Nathan
  2. J. List
  3. Wook Kim

Papers from Renee E. Amori's perspective

Ordered by how strongly the researchers Renee E. Amori trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Quantifying heterogeneity in a meta‐analysis (Statistics in Medicine)
  2. Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. (Diabetes Care)
  3. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes. (Diabetes Care)
  4. Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. (Journal of Clinical Endocrinology and Metabolism)
  5. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. (The Lancet)
  6. Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a… (Diabetes, obesity and metabolism)
  7. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus (Diabetologia)
  8. How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS
  9. Controlling the risk of spurious findings from meta‐regression (Statistics in Medicine)
  10. Random-effects model for meta-analysis of clinical trials: an update. (Contemporary Clinical Trials)

Their papers